{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:42:54Z","timestamp":1740163374677,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007653","name":"Universit\u00e4tsklinikum Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Butylscopolamine (or hyoscine butylbromide, trade name Buscopan<jats:sup>\u00ae<\/jats:sup>) is occasionally administered as a premedication to reduce non-specific FDG uptake in the gastrointestinal tract based on its antiperistaltic effect. To date, there are no consistent recommendations for its use. The aim of this study was to quantify the reduction in intestinal and non-intestinal uptake by butylscopolamine administration and to derive relevance for clinical evaluation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>458 patients (PET\/CT for lung cancer) were retrospectively reviewed. 218 patients with butylscopolamine and 240 patients without butylscopolamine had comparable characteristics. While the SUV<jats:sub>mean<\/jats:sub> in the gullet\/stomach and small intestine was significantly reduced with butylscopolamine, the colon and rectum\/anus showed no difference. The liver and salivary glands showed a reduced SUV<jats:sub>mean<\/jats:sub>, while skeletal muscle and blood pool were unaffected. An effect of butylscopolamine was particularly evident in men and patients under 65\u00a0years of age. There was no difference in the perceived confidence in the assessment of intestinal findings in the subjective evaluation, although in the butylscopolamine group further diagnostics appeared advisable more frequently.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Butylscopolamine reduces gastrointestinal FDG accumulation only in selected segments and, despite a significant effect, only to a small extent. A general recommendation for the use of butylscopolamine cannot be derived from these results, its use for specific issues could be considered individually.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13550-023-01012-2","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T16:02:43Z","timestamp":1687276963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of butylscopolamine on [18F]FDG uptake in the gastrointestinal tract is negligible and regionally variable"],"prefix":"10.1186","volume":"13","author":[{"given":"Falk","family":"G\u00fchne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinand","family":"Ndum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Winkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Drescher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6462-3851","authenticated-orcid":false,"given":"Martin","family":"Freesmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"issue":"Suppl 1","key":"1012_CR1","doi-asserted-by":"publisher","first-page":"31S","DOI":"10.2967\/jnumed.108.057216","volume":"50","author":"RJ Hicks","year":"2009","unstructured":"Hicks RJ. Role of 18F-FDG PET in assessment of response in non-small cell lung cancer. J Nucl Med. 2009;50(Suppl 1):31S-42S. https:\/\/doi.org\/10.2967\/jnumed.108.057216.","journal-title":"J Nucl Med"},{"key":"1012_CR2","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.diii.2016.06.020","volume":"97","author":"D Groheux","year":"2016","unstructured":"Groheux D, Quere G, Blanc E, Lemarignier C, Vercellino L, de Margerie-Mellon C, et al. FDG PET-CT for solitary pulmonary nodule and lung cancer: literature review. Diagn Interv Imaging. 2016;97:1003\u201317. https:\/\/doi.org\/10.1016\/j.diii.2016.06.020.","journal-title":"Diagn Interv Imaging"},{"key":"1012_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1053\/j.semnuclmed.2021.06.008","volume":"51","author":"JP Pijl","year":"2021","unstructured":"Pijl JP, Nienhuis PH, Kwee TC, Glaudemans A, Slart R, Gormsen LC. Limitations and Pitfalls of FDG-PET\/CT in Infection and Inflammation. Semin Nucl Med. 2021;51:633\u201345. https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.06.008.","journal-title":"Semin Nucl Med"},{"key":"1012_CR4","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1007\/s00330-005-0088-y","volume":"16","author":"SJ Rosenbaum","year":"2006","unstructured":"Rosenbaum SJ, Lind T, Antoch G, Bockisch A. False-positive FDG PET uptake\u2013the role of PET\/CT. Eur Radiol. 2006;16:1054\u201365. https:\/\/doi.org\/10.1007\/s00330-005-0088-y.","journal-title":"Eur Radiol"},{"key":"1012_CR5","first-page":"145","volume":"33","author":"MM Abouzied","year":"2005","unstructured":"Abouzied MM, Crawford ES, Nabi HA. 18F-FDG imaging: pitfalls and artifacts. J Nucl Med Technol. 2005;33:145\u201355.","journal-title":"J Nucl Med Technol"},{"key":"1012_CR6","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40644-020-00344-9","volume":"20","author":"D Dudoignon","year":"2020","unstructured":"Dudoignon D, Pattison DA, Legallois D, Hicks RJ, Aide N. The utility of pharmacological and radiological interventions to optimize diagnostic information from PET\/CT. Cancer Imaging. 2020;20:68. https:\/\/doi.org\/10.1186\/s40644-020-00344-9.","journal-title":"Cancer Imaging"},{"key":"1012_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1148\/rg.271065080","volume":"27","author":"HB Prabhakar","year":"2007","unstructured":"Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA. Bowel hot spots at PET-CT. Radiographics. 2007;27:145\u201359. https:\/\/doi.org\/10.1148\/rg.271065080.","journal-title":"Radiographics"},{"key":"1012_CR8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1967\/s002449910407","volume":"19","author":"SR Soltau","year":"2016","unstructured":"Soltau SR, Hess S, Nguyen T, Gerke O, Petersen H, Alavi A, et al. Clinical significance of incidental focal bowel uptake on (18)F-FDG PET\/CT as related to colorectal cancer. Hell J Nucl Med. 2016;19:245\u20139. https:\/\/doi.org\/10.1967\/s002449910407.","journal-title":"Hell J Nucl Med"},{"key":"1012_CR9","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","volume":"157","author":"T Dyba","year":"2021","unstructured":"Dyba T, Randi G, Bray F, Martos C, Giusti F, Nicholson N, et al. The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers. Eur J Cancer. 2021;157:308\u201347. https:\/\/doi.org\/10.1016\/j.ejca.2021.07.039.","journal-title":"Eur J Cancer"},{"key":"1012_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34479","author":"KA Cronin","year":"2022","unstructured":"Cronin KA, Scott S, Firth AU, Sung H, Henley SJ, Sherman RL, et al. Annual report to the nation on the status of cancer, part 1: national cancer statistics. Cancer. 2022. https:\/\/doi.org\/10.1002\/cncr.34479.","journal-title":"Cancer"},{"key":"1012_CR11","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1007\/s00330-010-1772-0","volume":"20","author":"W Luboldt","year":"2010","unstructured":"Luboldt W, Volker T, Wiedemann B, Zophel K, Wehrmann U, Koch A, et al. Detection of relevant colonic neoplasms with PET\/CT: promising accuracy with minimal CT dose and a standardised PET cut-off. Eur Radiol. 2010;20:2274\u201385. https:\/\/doi.org\/10.1007\/s00330-010-1772-0.","journal-title":"Eur Radiol"},{"key":"1012_CR12","doi-asserted-by":"publisher","first-page":"967","DOI":"10.14309\/ajg.0000000000001146","volume":"116","author":"F Guo","year":"2021","unstructured":"Guo F, Chen C, Holleczek B, Schottker B, Hoffmeister M, Brenner H. Strong reduction of colorectal cancer incidence and mortality after screening colonoscopy: prospective cohort study from Germany. Am J Gastroenterol. 2021;116:967\u201375. https:\/\/doi.org\/10.14309\/ajg.0000000000001146.","journal-title":"Am J Gastroenterol"},{"key":"1012_CR13","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.gie.2010.10.047","volume":"73","author":"N Takano","year":"2011","unstructured":"Takano N, Yamada A, Watabe H, Togo G, Yamaji Y, Yoshida H, et al. Single-balloon versus double-balloon endoscopy for achieving total enteroscopy: a randomized, controlled trial. Gastrointest Endosc. 2011;73:734\u20139. https:\/\/doi.org\/10.1016\/j.gie.2010.10.047.","journal-title":"Gastrointest Endosc"},{"doi-asserted-by":"publisher","unstructured":"Chatelanat O, Spahr L, Bichard P, Bochatay L, Goossens N, Bastid C, et al. Evaluation of 30-day mortality in patients undergoing gastrointestinal endoscopy in a tertiary hospital: a 3-year retrospective survey. BMJ Open Gastroenterol. 2022;9. doi:https:\/\/doi.org\/10.1136\/bmjgast-2022-000977.","key":"1012_CR14","DOI":"10.1136\/bmjgast-2022-000977"},{"key":"1012_CR15","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ejrad.2012.11.023","volume":"82","author":"N Venkatanarasimha","year":"2013","unstructured":"Venkatanarasimha N, Jenkins SJ, Yang N, Colak E, Kirpalani A. Impact of butylscopolamine on image quality of magnetic resonance cholangiopancreatography. Eur J Radiol. 2013;82:583\u20138. https:\/\/doi.org\/10.1016\/j.ejrad.2012.11.023.","journal-title":"Eur J Radiol"},{"key":"1012_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/1754-9485.13033","volume":"64","author":"A Rao","year":"2020","unstructured":"Rao A, Sitheeque F, Gustafson S, Lu M, Prior M. MR enterography - impact on image quality between single- versus split-dose Buscopan. J Med Imaging Radiat Oncol. 2020;64:331\u20137. https:\/\/doi.org\/10.1111\/1754-9485.13033.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"1012_CR17","doi-asserted-by":"publisher","first-page":"110222","DOI":"10.1016\/j.ejrad.2022.110222","volume":"149","author":"IA Ciggaar","year":"2022","unstructured":"Ciggaar IA, Henneman ODF, Oei SA, Vanhooymissen I, Blikkendaal MD, Bipat S. Bowel preparation in MRI for detection of endometriosis: comparison of the effect of an enema, no additional medication and intravenous butylscopolamine on image quality. Eur J Radiol. 2022;149:110222. https:\/\/doi.org\/10.1016\/j.ejrad.2022.110222.","journal-title":"Eur J Radiol."},{"key":"1012_CR18","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/mrm.28824","volume":"86","author":"C Bilreiro","year":"2021","unstructured":"Bilreiro C, Fernandes FF, Andrade L, Chavarrias C, Simoes RV, Matos C, et al. Effective bowel motion reduction in mouse abdominal MRI using hyoscine butylbromide. Magn Reson Med. 2021;86:2146\u201355. https:\/\/doi.org\/10.1002\/mrm.28824.","journal-title":"Magn Reson Med"},{"key":"1012_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00330-017-4940-7","volume":"28","author":"T Ullrich","year":"2018","unstructured":"Ullrich T, Quentin M, Schmaltz AK, Arsov C, Rubbert C, Blondin D, et al. Hyoscine butylbromide significantly decreases motion artefacts and allows better delineation of anatomic structures in mp-MRI of the prostate. Eur Radiol. 2018;28:17\u201323. https:\/\/doi.org\/10.1007\/s00330-017-4940-7.","journal-title":"Eur Radiol"},{"key":"1012_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/MNM.0b013e3282f1d706","volume":"29","author":"J Emmott","year":"2008","unstructured":"Emmott J, Sanghera B, Chambers J, Wong WL. The effects of N-butylscopolamine on bowel uptake: an 18F-FDG PET study. Nucl Med Commun. 2008;29:11\u20136. https:\/\/doi.org\/10.1097\/MNM.0b013e3282f1d706.","journal-title":"Nucl Med Commun"},{"key":"1012_CR21","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s12149-009-0263-3","volume":"23","author":"B Sanghera","year":"2009","unstructured":"Sanghera B, Emmott J, Wellsted D, Chambers J, Wong WL. Influence of N-butylscopolamine on SUV in FDG PET of the bowel. Ann Nucl Med. 2009;23:471\u20138. https:\/\/doi.org\/10.1007\/s12149-009-0263-3.","journal-title":"Ann Nucl Med"},{"key":"1012_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1055\/s-0038-1632274","volume":"39","author":"A Stahl","year":"2000","unstructured":"Stahl A, Weber WA, Avril N, Schwaiger M. Effect of N-butylscopolamine on intestinal uptake of fluorine-18-fluorodeoxyglucose in PET imaging of the abdomen. Nuklearmedizin. 2000;39:241\u20135.","journal-title":"Nuklearmedizin"},{"key":"1012_CR23","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1185\/03007990802472700","volume":"24","author":"GN Tytgat","year":"2008","unstructured":"Tytgat GN. Hyoscine butylbromide - a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures. Curr Med Res Opin. 2008;24:3159\u201373. https:\/\/doi.org\/10.1185\/03007990802472700.","journal-title":"Curr Med Res Opin"},{"key":"1012_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328\u201354. https:\/\/doi.org\/10.1007\/s00259-014-2961-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1012_CR25","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.legalmed.2005.11.001","volume":"8","author":"H Ikegaya","year":"2006","unstructured":"Ikegaya H, Saka K, Sakurada K, Nakamura M, Yoshida K. A case of sudden death after intramuscular injection of butylscopolamine bromide. Leg Med. 2006;8:194\u20137. https:\/\/doi.org\/10.1016\/j.legalmed.2005.11.001.","journal-title":"Leg Med"},{"key":"1012_CR26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13550-017-0318-8","volume":"7","author":"JY Kang","year":"2017","unstructured":"Kang JY, Kim HN, Chang Y, Yun Y, Ryu S, Shin H, et al. Gut microbiota and physiologic bowel (18)F-FDG uptake. EJNMMI Res. 2017;7:72. https:\/\/doi.org\/10.1186\/s13550-017-0318-8.","journal-title":"EJNMMI Res"},{"key":"1012_CR27","first-page":"577","volume":"65","author":"C Prinz","year":"1992","unstructured":"Prinz C, Kajimura M, Scott D, Helander H, Shin J, Besancon M, et al. Acid secretion and the H, K ATPase of stomach. Yale J Biol Med. 1992;65:577\u201396.","journal-title":"Yale J Biol Med"},{"key":"1012_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222313153","author":"A Schledwitz","year":"2021","unstructured":"Schledwitz A, Sundel MH, Alizadeh M, Hu S, Xie G, Raufman JP. Differential actions of muscarinic receptor subtypes in gastric, pancreatic, and colon cancer. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222313153.","journal-title":"Int J Mol Sci."},{"key":"1012_CR29","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/BF02984589","volume":"18","author":"F Yamamoto","year":"2004","unstructured":"Yamamoto F, Nakada K, Zhao S, Satoh M, Asaka M, Tamaki N. Gastrointestinal uptake of FDG after N-butylscopolamine or omeprazole treatment in the rat. Ann Nucl Med. 2004;18:637\u201340. https:\/\/doi.org\/10.1007\/BF02984589.","journal-title":"Ann Nucl Med"},{"key":"1012_CR30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF03027388","volume":"19","author":"H Otsuka","year":"2005","unstructured":"Otsuka H, Graham MM, Kubo A, Nishitani H. The effect of oral contrast on large bowel activity in FDG-PET\/CT. Ann Nucl Med. 2005;19:101\u20138. https:\/\/doi.org\/10.1007\/BF03027388.","journal-title":"Ann Nucl Med"},{"key":"1012_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12149-010-0439-x","volume":"25","author":"A Toriihara","year":"2011","unstructured":"Toriihara A, Yoshida K, Umehara I, Shibuya H. Normal variants of bowel FDG uptake in dual-time-point PET\/CT imaging. Ann Nucl Med. 2011;25:173\u20138. https:\/\/doi.org\/10.1007\/s12149-010-0439-x.","journal-title":"Ann Nucl Med"},{"key":"1012_CR32","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1148\/radiol.2018180078","volume":"289","author":"R Hamidizadeh","year":"2018","unstructured":"Hamidizadeh R, Eftekhari A, Wiley EA, Wilson D, Alden T, Benard F. Metformin discontinuation prior to FDG PET\/CT: a randomized controlled study to compare 24- and 48-hour bowel activity. Radiology. 2018;289:418\u201325. https:\/\/doi.org\/10.1148\/radiol.2018180078.","journal-title":"Radiology"},{"key":"1012_CR33","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s00259-015-3211-6","volume":"43","author":"PY Le Roux","year":"2016","unstructured":"Le Roux PY, Duong CP, Cabalag CS, Parameswaran BK, Callahan J, Hicks RJ. Incremental diagnostic utility of gastric distension FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2016;43:644\u201353. https:\/\/doi.org\/10.1007\/s00259-015-3211-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1012_CR34","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s002590100561","volume":"28","author":"WA Hallett","year":"2001","unstructured":"Hallett WA, Marsden PK, Cronin BF, O\u2019Doherty MJ. Effect of corrections for blood glucose and body size on [18F]FDG PET standardised uptake values in lung cancer. Eur J Nucl Med. 2001;28:919\u201322. https:\/\/doi.org\/10.1007\/s002590100561.","journal-title":"Eur J Nucl Med"},{"key":"1012_CR35","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/RLU.0000000000003576","volume":"46","author":"T Winkens","year":"2021","unstructured":"Winkens T, Rudakoff W, Rauchfuss F, Malessa C, Settmacher U, Freesmeyer M. FDG PET\/CT to detect incidental findings in patients with hepatocellular carcinoma-additional benefit for patients considered for liver transplantation? Clin Nucl Med. 2021;46:532\u20139. https:\/\/doi.org\/10.1097\/RLU.0000000000003576.","journal-title":"Clin Nucl Med"},{"key":"1012_CR36","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00259-005-0056-4","volume":"33","author":"E Even-Sapir","year":"2006","unstructured":"Even-Sapir E, Lerman H, Gutman M, Lievshitz G, Zuriel L, Polliack A, et al. The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT. Eur J Nucl Med Mol Imaging. 2006;33:541\u201352. https:\/\/doi.org\/10.1007\/s00259-005-0056-4.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1012_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1148\/radiol.2302021685","volume":"230","author":"H Agress Jr","year":"2004","unstructured":"Agress H Jr, Cooper BZ. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison. Radiology. 2004;230:417\u201322. https:\/\/doi.org\/10.1148\/radiol.2302021685.","journal-title":"Radiology"},{"key":"1012_CR38","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/ddg.12924","volume":"14","author":"F Conrad","year":"2016","unstructured":"Conrad F, Winkens T, Kaatz M, Goetze S, Freesmeyer M. Retrospective chart analysis of incidental findings detected by (18) F-fluorodeoxyglucose-PET\/CT in patients with cutaneous malignant melanoma. J Dtsch Dermatol Ges. 2016;14:807\u201316. https:\/\/doi.org\/10.1111\/ddg.12924.","journal-title":"J Dtsch Dermatol Ges"},{"key":"1012_CR39","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.remn.2014.07.008","volume":"34","author":"J Fuertes","year":"2015","unstructured":"Fuertes J, Montagut C, Bullich S, Coma MI, Mestre-Fusco A, Suarez-Pinera M, et al. Incidental focal uptake in colorectal location on oncologic (1)(8)FDG PET and PET\/CT studies: histopathological findings and clinical significances. Rev Esp Med Nucl Imagen Mol. 2015;34:95\u2013101. https:\/\/doi.org\/10.1016\/j.remn.2014.07.008.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"1012_CR40","first-page":"758","volume":"46","author":"O Israel","year":"2005","unstructured":"Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z, et al. PET\/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med. 2005;46:758\u201362.","journal-title":"J Nucl Med"},{"key":"1012_CR41","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.remn.2011.03.014","volume":"31","author":"G Salazar Andia","year":"2012","unstructured":"Salazar Andia G, Prieto Soriano A, Ortega Candil A, Cabrera Martin MN, Gonzalez Roiz C, Ortiz Zapata JJ, et al. Clinical relevance of incidental finding of focal uptakes in the colon during 18F-FDG PET\/CT studies in oncology patients without known colorectal carcinoma and evaluation of the impact on management. Rev Esp Med Nucl Imagen Mol. 2012;31:15\u201321. https:\/\/doi.org\/10.1016\/j.remn.2011.03.014.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"1012_CR42","first-page":"4143","volume":"17","author":"A Kunawudhi","year":"2016","unstructured":"Kunawudhi A, Wong AK, Alkasab TK, Mahmood U. Accuracy of FDG-PET\/CT for detection of incidental pre-malignant and malignant colonic lesions - correlation with colonoscopic and histopathologic findings. Asian Pac J Cancer Prev. 2016;17:4143\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1012_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00259-007-0563-6","volume":"35","author":"E Gontier","year":"2008","unstructured":"Gontier E, Fourme E, Wartski M, Blondet C, Bonardel G, Le Stanc E, et al. High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging. 2008;35:95\u20139. https:\/\/doi.org\/10.1007\/s00259-007-0563-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1012_CR44","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.diabres.2017.07.015","volume":"131","author":"JP Koffert","year":"2017","unstructured":"Koffert JP, Mikkola K, Virtanen KA, Andersson AD, Faxius L, Hallsten K, et al. Metformin treatment significantly enhances intestinal glucose uptake in patients with type 2 diabetes: Results from a randomized clinical trial. Diabetes Res Clin Pract. 2017;131:208\u201316. https:\/\/doi.org\/10.1016\/j.diabres.2017.07.015.","journal-title":"Diabetes Res Clin Pract"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-023-01012-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-023-01012-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-023-01012-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T16:08:35Z","timestamp":1687277315000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-023-01012-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1186\/s13550-023-01012-2","relation":{},"ISSN":["2191-219X"],"issn-type":[{"type":"electronic","value":"2191-219X"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"assertion":[{"value":"12 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Internal ethics committee of Jena University Hospital confirmed scientific evaluation of routinely collected data with registration number <i>2021\u20132208-Daten<\/i>. All patients gave full informed consent for clinically indicated PET\/CT examination. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}